Broderick Brian C lowered its stake in shares of CVS Health Corporation (NYSE:CVS) by 2.0% during the second quarter, Holdings Channel reports. The institutional investor owned 92,191 shares of the pharmacy operator’s stock after selling 1,910 shares during the period. CVS Health Corporation accounts for approximately 3.7% of Broderick Brian C’s portfolio, making the stock its 4th largest position. Broderick Brian C’s holdings in CVS Health Corporation were worth $8,824,000 as of its most recent filing with the SEC.

Several other hedge funds have also modified their holdings of the stock. Hemenway Trust Co LLC raised its position in shares of CVS Health Corporation by 1.4% in the second quarter. Hemenway Trust Co LLC now owns 143,336 shares of the pharmacy operator’s stock worth $13,723,000 after buying an additional 1,910 shares during the period. Notis McConarty Edward raised its position in shares of CVS Health Corporation by 0.5% in the second quarter. Notis McConarty Edward now owns 45,651 shares of the pharmacy operator’s stock worth $4,371,000 after buying an additional 210 shares during the period. Oppenheimer & Co. Inc. raised its position in shares of CVS Health Corporation by 3.2% in the second quarter. Oppenheimer & Co. Inc. now owns 127,486 shares of the pharmacy operator’s stock worth $12,205,000 after buying an additional 3,921 shares during the period. CENTRAL TRUST Co raised its position in shares of CVS Health Corporation by 2.9% in the second quarter. CENTRAL TRUST Co now owns 71,583 shares of the pharmacy operator’s stock worth $6,853,000 after buying an additional 2,024 shares during the period. Finally, CFO4Life L.P. raised its position in shares of CVS Health Corporation by 3.0% in the second quarter. CFO4Life L.P. now owns 3,778 shares of the pharmacy operator’s stock worth $362,000 after buying an additional 109 shares during the period. Hedge funds and other institutional investors own 81.08% of the company’s stock.

CVS Health Corporation (NYSE:CVS) traded up 1.09% during mid-day trading on Tuesday, hitting $90.14. 4,142,685 shares of the stock traded hands. The stock’s 50 day moving average is $94.74 and its 200-day moving average is $98.04. The company has a market cap of $96.11 billion, a price-to-earnings ratio of 20.74 and a beta of 0.84. CVS Health Corporation has a 12 month low of $86.50 and a 12 month high of $106.67.

CVS Health Corporation (NYSE:CVS) last posted its quarterly earnings results on Tuesday, August 2nd. The pharmacy operator reported $1.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.30 by $0.02. The firm earned $43.70 billion during the quarter, compared to analysts’ expectations of $44.28 billion. CVS Health Corporation had a net margin of 2.88% and a return on equity of 15.86%. The firm’s revenue for the quarter was up 17.6% on a year-over-year basis. During the same period in the prior year, the company posted $1.19 earnings per share. On average, equities research analysts anticipate that CVS Health Corporation will post $5.86 EPS for the current year.

A number of equities analysts recently issued reports on CVS shares. Mizuho raised their target price on CVS Health Corporation from $108.00 to $111.00 and gave the stock a “buy” rating in a research note on Thursday, August 4th. Leerink Swann restated a “buy” rating on shares of CVS Health Corporation in a research note on Wednesday, August 3rd. Credit Suisse Group AG restated a “buy” rating and issued a $115.00 target price on shares of CVS Health Corporation in a research note on Sunday, June 5th. Jefferies Group restated a “buy” rating on shares of CVS Health Corporation in a research note on Monday, July 4th. Finally, Argus restated a “buy” rating and issued a $120.00 target price on shares of CVS Health Corporation in a research note on Thursday, August 4th. Six analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has given a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average target price of $113.02.

CVS Health Corporation Company Profile

CVS Health Corporation, together with its subsidiaries, is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services, Novologix and Navarro Health Services names.

5 Day Chart for NYSE:CVS

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).

Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.